rs202037016
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PP3PP5
The NM_000359.3(TGM1):c.1075G>A(p.Val359Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,614,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V359V) has been classified as Likely benign.
Frequency
Consequence
NM_000359.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TGM1 | NM_000359.3 | c.1075G>A | p.Val359Met | missense_variant | 7/15 | ENST00000206765.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TGM1 | ENST00000206765.11 | c.1075G>A | p.Val359Met | missense_variant | 7/15 | 1 | NM_000359.3 | P1 | |
TGM1 | ENST00000559136.1 | c.148G>A | p.Val50Met | missense_variant | 3/7 | 5 | |||
TGM1 | ENST00000544573.5 | c.-28-771G>A | intron_variant | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251160Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135784
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461844Hom.: 0 Cov.: 34 AF XY: 0.0000206 AC XY: 15AN XY: 727218
GnomAD4 genome ? AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74360
ClinVar
Submissions by phenotype
Autosomal recessive congenital ichthyosis 1 Pathogenic:2Uncertain:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 01, 2009 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Feb 03, 2017 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 30, 2024 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Invitae | Aug 29, 2023 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 359 of the TGM1 protein (p.Val359Met). This variant is present in population databases (rs202037016, gnomAD 0.0009%). This missense change has been observed in individuals with congenital ichthyosis ( (PMID: 19241467, 19500103). ClinVar contains an entry for this variant (Variation ID: 39532). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TGM1 protein function. Experimental studies have shown that this missense change affects TGM1 function (PMID: 19500103). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 03, 2023 | Variant summary: TGM1 c.1075G>A (p.Val359Met) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251160 control chromosomes. c.1075G>A has been reported in the literature as a compound heterozygous genotype in at-least two individuals affected with features of Autosomal recessive congenital ichthyosis (ARCI) or a novel phenotype of acral self-healing collodion baby (example, Herman_2009, Mazereeuw-Hautier_2009). The case report describing the novel phenotype of acral self-healing collodion baby reports its presence in a family with three segregating variants in the TGM1 gene (Mazereeuw-Hautier_2009). The proband was compound heterozygous for this paternally inherited variant and a maternally inherited p.Arg396His variant. While the sister was compound heterozygous for a different paternally inherited variant (c.1922_1926+2delGGCCTGT) and maternally inherited p.Arg396His variant seen in her proband sibling. The father who carries the deletion and the p.Val359Met mutation was reported as having no clinical symptoms, although the authors did not rule out the possibility that he was not aware of a very transient and mild anomaly of his skin at birth.. These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function (Mazereeuw-Hautier_2009). The most pronounced variant effect results in 12.8% of normal recombinant transglutaminase enzyme activity in-vitro. The following publications have been ascertained in the context of this evaluation (PMID: 19241467, 19500103). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. One laboratory classified the variant as likely pathogenic and one laboratory classified the variant as uncertain significance. Both labs cite overlapping evidence utilized in the context of this evaluation. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at